Panels, Seminars and Workshops
Xihong Lin, PhD
Professor, Department of Biostatistics
Harvard T.H. Chan School of Public Health
Tuesday, February 23, 2021
- Credits: OPAC
In this short video, Yale’s Dr. Howard Forman, physician and professor, discusses herd immunity — what it is and how to achieve it for maximum benefit in the age of COVID-19.
YSPH Dean's Lecture and HPM Seminar: Lessons Learned in Navigating Healthcare in a COVID-19 Pandemic Environment
December 16, 2020
Prathibha Varkey, MBBS, MPH, MBA, MHPE
Professor of Medicine (General Medicine), Yale School of Medicine
Professor of Health Policy and Management, Yale School of Public Health
CEO and President, Northeast Medical Group
Dr. Prathibha Varkey is the President and CEO of the Northeast Medical Group (NEMG) and Senior Vice President of Yale New Haven Health. NEMG is home to over 1100 physicians and advanced care practitioners serving Yale New Haven, Bridgeport, Greenwich and Lawrence and Memorial Hospitals and over 120 outpatient clinic sites in Connecticut, New York and Rhode Island. She is also adjunct professor of Medicine and of Preventive Medicine at Mayo Clinic. Dr. Varkey is the editor of two books: Medical Quality Management and Preventive Medicine and Public Health and author of more than 75 publications.
Dr. Varkey previously served as the CEO of the Clinical Enterprise, a large multispecialty group at Seton Family Healthcare, Austin, Texas as well as in a number of leadership positions at Mayo Clinic, including as the Associate Chair of the Department of Medicine; Medical Director of Ask Mayo Clinic (national nurse triage line); Medical Director of the Value Program at the Mayo Clinic Center for the Science of Healthcare Delivery; Vice Chair of the Mayo Clinic Outpatient Practice Committee and Program Director for the Mayo Preventive Medicine Fellowship.
Dr. Varkey is the recipient of many national awards including the American Medical Association Foundation Physician Leadership Award, the ACGME Parker Palmer Courage to Teach Award, the American College of Medical Quality President’s Award, the Mayo Clinic Individual Excellence Award, the American Medical Women’s Association Exceptional Mentoring Award and the World Woman Leadership Congress Visionary Woman Leadership Award. She is a past President of the American College of Medical Quality and currently serves on the boards of the Lawrence and Memorial hospital, the University of New Haven and the Central CT YMCA.
Dr. Varkey earned her MBBS (MD equivalent) from the Christian Medical College, Vellore, India; a Masters of Public Health from the Harvard School of Public Health, Boston; Masters of Health Professions Education from the University of Illinois Chicago and a Masters of Business Administration from the Carlson School of Management at the University of Minnesota.
November 10, 2020.
In collaboration with the Nordic Center for Sustainable Healthcare, Dr. Jodi Sherman (Director - Program on Healthcare Environmental Sustainability) moderated a discussion on how the Covid-19 pandemic has exposed vulnerabilities in the global healthcare supply chain, and the opportunities for establishing a more robust and resilient supply chain.
Speakers & their topics included:
Rosemary Kumwenda, MD, MPH United Nations Development Program; Sustainable Procurement in Healthcare Coordinator “Lessons from sustainable procurement in the health sector: challenges & opportunities”
Patrick Kenney, MD Associate Professor of Urology, Yale School of Medicine; Medical Director of Corporate Supply Chain, Yale New Haven Health System; Founder and Chair, Supply Chain Physician Collaboration, Large Integrated Delivery Network “Covid-19, physicians & supplies: Inability to supply PPE is not the true supply chain crisis”
Benn Lawson, PhD, MCIPS Associate Professor of Operations Management, Judge Business School, University of Cambridge “Design and management of a resilient supply chain”
Ornella Benedettini, PhD, ING-IND Visiting Research Fellow, Judge Business School, University of Cambridge “The servitization business model: From products to use-oriented services”
Andreas Hagnell SKR (Swedish Association of Local Authorities and Regions) “Carbon disclosure in Swedish healthcare: How to include the scope 3 emissions”
Adam Robinson, BS Former Chairperson, Association of Medical Devices Reprocessors; Regional Director, HoverTech International “The reprocessing industry and the impact of Covid-19 on the reverse supply chain”
David Benseker, PhD, MPH, Assistant Professor
Emory University Department of Biostatistics and Bioinformatics.
October 27, 2020
Abstract: One of the best hopes we have of returning life to normal is to bring a safe and effective preventive COVID-19 vaccine to market and make it available to just about everybody around the world. We are in the middle of an unprecedented effort to bring such a vaccine to market. After a recent pressure campaign led by academic scientists, vaccine developers have made public the protocols for their Phase III trials. The release of these protocols has ignited a fierce debate as to whether the designs are appropriate and sufficiently safe-guarded from political pressure for vaccine approval. In this talk I will discuss a few of the complex issues involved in designing Phase III COVID vaccine trials, touching on some key statistical aspects of the trials along the way.
The Yale School of Public Health (YSPH) is honored to host Connecticut Governor Ned Lamont as he welcomes students back to campus for the Fall semester and discusses Connecticut’s COVID-19 efforts. Governor Lamont will be joined by a distinguished panel of guests including:
• Dr. Albert Ko, MD - YSPH Professor and Chair of Epidemiology of Microbial Diseases; Co-chair of the Reopen Connecticut Advisory Group
• Indra Nooyi (Yale SOM ’80) - Co-chair of the Reopen Connecticut Advisory Group; Board co-chair of Advance CT; former CEO of PepsiCo
• Maritza Bond, MPH – Director of Health for the City of New Haven
YSPH Dean Sten H. Vermund will serve as moderator for this event.
Guests will also be greeted by President Peter Salovey and City of New Haven Mayor, Justin Elicker.
Governor Ned Lamont was sworn into office in 2019 as the 89th Governor of the State of Connecticut. An alumnus of the Yale School of Management (MBA ’80), Governor Lamont is the first Connecticut Governor in 80 years to get his start as a businessman and job creator. He is the founder of Lamont Digital Systems, a telecommunications company and began his political career as a member of the Greenwich, CT Board of Selectmen and Board of Estimation and Taxation. As Governor, he formed the Reopen Connecticut Advisory Group in response to the COVID-19 pandemic. The group consists of leaders from business and public health, working in partnership with the State of Connecticut to determine when and how to reopen the economy and education systems. To do so, they have had to balance the two pressing priorities of economic concerns with public health implications.
How do we trace the origins of viral outbreaks? How do viruses change hosts? What can evolution tell us how long a recovered person will be immune before reinfection? And how do a marine biologist and a fungal geneticist end up working together on virus evolution? This week, join Drs. Jeffrey Townsend (Yale University) and Alex Dornburg (Museum and UNC Charlotte) for an informal conversation about how scientists have mobilized to face evolving threats to human health.
BIS Seminar - 6.23.2020 - Model-averaged estimation of molecular evolution and natural selection in SARS-COV-1 and SARS-CoV-2 coronaviruses during zoonosis
Jeffrey Townsend, PhD
Elihu Professor of Biostatistics and Professor of Ecology and Evolutionary Biology
Biostatistics Seminar - 6.9.2020
Frank Harrel, Professor of Biostatistics
Vanderbilt University School of Medicine
Associate Professor of Biostatistics, Statistics & Data Science, Operation, and Ecology & Evolutionary Biology
5.25.2020 Biostatistics Seminar
Nancy Brown, M.D., Jean and David W. Wallace Dean of the Yale School of Medicine, hosts a virtual conversation highlighting the extraordinary efforts being made across the Yale campus to conquer the COVID-19 pandemic.
FEATURING • Jeffrey Brock, Ph.D., Dean, Yale School of Engineering & Applied Science; Dean of Science, Faculty of Arts & Sciences • Ellen Foxman, M.D., Ph.D., Assistant Professor of Laboratory Medicine and of Immunobiology • Murat Gunel, M.D., Nixdorff-German Professor of Neurosurgery; Chief, Neurosurgery, Yale New Haven Health System • Akiko Iwasaki, Ph.D., Waldemar Von Zedtwitz Professor of Immunobiology • Harlan Krumholz, M.D., S.M., Harold H. Hines, Jr. Professor of Medicine; Director, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital • Saad Omer, Ph.D., MPH, Director, Yale Institute for Global Health; Susan Dwight Bliss Professor of Epidemiology of Microbial Diseases • Paul Taheri, M.D., MBA, Chief Executive Officer, Yale Medicine • Sten Vermund, M.D., Ph.D., Dean, Yale School of Public Health; Anna M.R. Lauder Professor of Public Health • Vincent Wilczynski, Ph.D., Deputy Dean, Yale School of Engineering & Applied Science • Craig Wilen, M.D., Ph.D., Assistant Professor of Laboratory Medicine and of Immunobiology; Medical Director, Immune Monitoring Core Facility
Originally recorded: Friday, May 8, 2020
Biostatistics Seminar: BETS: The dangers of selection bias in early analyses of the coronavirus disease (COVID-19) pandemic
Qingyuan Zhao, Statistical Laboratory, University of Cambridge
May 5, 2020
Robert Dubrow, MD, PhD, Professor of Epidemiology (Environmental Health Sciences); Faculty Director, Yale Center on Climate Change and Health, Environmental Health Sciences
April 2, 2020
Dan Weinberger, PhD, associate professor of Epidemiology (Microbial Diseases), Yale School of Public Health April 2020 Seminar
Anne Wyllie, PhD, Associate Research Scientist
April 27, 2020
Panelists: Lauretta Grau, PhD - Research Scientist in Epidemiology of Microbial Diseases, Yale School of Public Health
Kaveh Khoshnood, PhD, MPH - Associate Professor of Epidemiology of Microbial Diseases, Yale School of Public Health
James Hadler, MD, MPH – Clinical Professor of Epidemiology, Yale School of Public Health, and Senior Infectious Disease and Medical Epidemiology Consultant to the Connecticut and Yale Emerging Infections Programs, the New York City Department of Health and Mental Hygiene and the Council of State and Territorial Epidemiologists
Moderator: Gerald Friedland, MD - Professor Emeritus of and Senior Research Scientist in Medicine (Infectious Diseases); Professor Emeritus of Medicine and Epidemiology and Public Health; Senior Research Scientist, Infectious DiseasesApril 27, 2020
Yale School of Public Health Partnerships With State And Local Health Departments For Covid-19 Response
Linda Niccolai, PhD, Professor of Epidemiology (Microbial Diseases)
Marcela Nunez-Smith, MD, MHS Associate Professor of Medicine and of Epidemiology (Chronic Diseases)
Marna Borgstrom, CEO Yale New Haven Health
Vincent Petrini, Senior Vice President & Chief Policy & Communications Officer
Nathan Grubaugh, PhD, Assistant Professor of Epidemiology (Microbial Diseases)
- Credits: Yale University, Yale School of Public Health
from Yale University and the Yale School of Public Health